Insider Selling: Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) CFO Cam Gallagher sold 9,597 shares of the business’s stock in a transaction on Friday, May 31st. The shares were sold at an average price of $11.98, for a total transaction of $114,972.06. Following the transaction, the chief financial officer now owns 633,680 shares in the company, […]

Related Keywords

Stifel Nicolaus , Nasdaq , Zentalis Pharmaceuticals Inc , Zentalis Pharmaceuticals Stock Performance , Vanguard Group Inc , Tower Research Capital , Sg Americas Securities , Quarter For Zentalis Pharmaceuticals , Zentalis Pharmaceuticals Company Profile , Charles Schwab Investment Management Inc , York Mellon Corp , News Ratings For Zentalis Pharmaceuticals Daily , Zentalis Pharmaceuticals , Get Free Report , Schwab Investment Management , Research Capital , New York Mellon Corp , Zentalis Pharmaceuticals Daily ,